肾嗜色细胞瘤模拟肾细胞癌:管理使用提出的诊断算法,重点99mTc-sestamibi SPECT/CT。

IF 1.6 Q2 MEDICINE, GENERAL & INTERNAL
Ryan K W Chee, Mitchell P Wilson, Gavin Low
{"title":"肾嗜色细胞瘤模拟肾细胞癌:管理使用提出的诊断算法,重点99mTc-sestamibi SPECT/CT。","authors":"Ryan K W Chee, Mitchell P Wilson, Gavin Low","doi":"10.5582/irdr.2025.01031","DOIUrl":null,"url":null,"abstract":"<p><p>Renal oncocytomas are benign renal tumours characterized by a central stellate scar that are indistinguishable on CT/MR imaging from malignant chromophobe renal cell carcinomas (ChrRCCs). Renal oncocytomas and ChrRCCs can be separate entities but can also co-exist on a spectrum in hybrid oncocytic/ chromophobe tumours. In the past, invasive biopsy and pathologic diagnosis has been relied on to differentiate these lesion and direct management. Early research demonstrates the effectiveness of technetium 99m sestamibi (99mTc-sestamibi) single-photon emission computed tomography (SPECT)/CT in differentiating benign versus malignant renal tumours. A new diagnostic algorithm has previously been proposed to reduce unnecessary biopsy and/or targeted therapy in managing enhancing 1-4 cm renal masses by incorporating 99mTc-sestamibi SPECT/CT in management. We present a case of suspected renal oncocytoma found incidentally on surveillance imaging post-treatment of uveal melanoma. We illustrate the incorporation of the proposed diagnostic algorithm using 99mTc-sestamibi SPECT/CT for enhancing 1-4 cm renal masses into the existing diagnostic algorithm for incidental renal masses and demonstrate its use in our case of suspected renal oncocytoma.</p>","PeriodicalId":14420,"journal":{"name":"Intractable & rare diseases research","volume":"14 3","pages":"232-235"},"PeriodicalIF":1.6000,"publicationDate":"2025-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12403895/pdf/","citationCount":"0","resultStr":"{\"title\":\"Renal oncocytoma mimicking chromophobe renal cell carcinoma: Management using proposed diagnostic algorithm with emphasis on 99mTc-sestamibi SPECT/CT.\",\"authors\":\"Ryan K W Chee, Mitchell P Wilson, Gavin Low\",\"doi\":\"10.5582/irdr.2025.01031\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Renal oncocytomas are benign renal tumours characterized by a central stellate scar that are indistinguishable on CT/MR imaging from malignant chromophobe renal cell carcinomas (ChrRCCs). Renal oncocytomas and ChrRCCs can be separate entities but can also co-exist on a spectrum in hybrid oncocytic/ chromophobe tumours. In the past, invasive biopsy and pathologic diagnosis has been relied on to differentiate these lesion and direct management. Early research demonstrates the effectiveness of technetium 99m sestamibi (99mTc-sestamibi) single-photon emission computed tomography (SPECT)/CT in differentiating benign versus malignant renal tumours. A new diagnostic algorithm has previously been proposed to reduce unnecessary biopsy and/or targeted therapy in managing enhancing 1-4 cm renal masses by incorporating 99mTc-sestamibi SPECT/CT in management. We present a case of suspected renal oncocytoma found incidentally on surveillance imaging post-treatment of uveal melanoma. We illustrate the incorporation of the proposed diagnostic algorithm using 99mTc-sestamibi SPECT/CT for enhancing 1-4 cm renal masses into the existing diagnostic algorithm for incidental renal masses and demonstrate its use in our case of suspected renal oncocytoma.</p>\",\"PeriodicalId\":14420,\"journal\":{\"name\":\"Intractable & rare diseases research\",\"volume\":\"14 3\",\"pages\":\"232-235\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-08-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12403895/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Intractable & rare diseases research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5582/irdr.2025.01031\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Intractable & rare diseases research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5582/irdr.2025.01031","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

肾嗜色细胞瘤是一种以中央星状疤痕为特征的良性肾肿瘤,在CT/MR成像上与恶性憎色肾细胞癌(ChrRCCs)难以区分。肾嗜瘤细胞瘤和肾嗜铬细胞癌可以是独立的实体,但在嗜瘤细胞/憎色细胞混合肿瘤的光谱上也可以共存。在过去,有创活检和病理诊断一直依赖于区分这些病变和指导治疗。早期研究证实了99mTc-sestamibi单光子发射计算机断层扫描(SPECT)/CT在鉴别肾肿瘤良恶性方面的有效性。先前提出了一种新的诊断算法,通过合并99mTc-sestamibi SPECT/CT来减少不必要的活检和/或靶向治疗,以管理增大的1-4厘米肾肿块。我们报告一例疑似肾嗜瘤细胞瘤,在葡萄膜黑色素瘤治疗后偶然发现的监测成像。我们展示了使用99mTc-sestamibi SPECT/CT增强1-4 cm肾肿块的诊断算法与现有的偶发性肾肿块诊断算法的结合,并展示了其在疑似肾嗜瘤细胞瘤病例中的应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Renal oncocytoma mimicking chromophobe renal cell carcinoma: Management using proposed diagnostic algorithm with emphasis on 99mTc-sestamibi SPECT/CT.

Renal oncocytomas are benign renal tumours characterized by a central stellate scar that are indistinguishable on CT/MR imaging from malignant chromophobe renal cell carcinomas (ChrRCCs). Renal oncocytomas and ChrRCCs can be separate entities but can also co-exist on a spectrum in hybrid oncocytic/ chromophobe tumours. In the past, invasive biopsy and pathologic diagnosis has been relied on to differentiate these lesion and direct management. Early research demonstrates the effectiveness of technetium 99m sestamibi (99mTc-sestamibi) single-photon emission computed tomography (SPECT)/CT in differentiating benign versus malignant renal tumours. A new diagnostic algorithm has previously been proposed to reduce unnecessary biopsy and/or targeted therapy in managing enhancing 1-4 cm renal masses by incorporating 99mTc-sestamibi SPECT/CT in management. We present a case of suspected renal oncocytoma found incidentally on surveillance imaging post-treatment of uveal melanoma. We illustrate the incorporation of the proposed diagnostic algorithm using 99mTc-sestamibi SPECT/CT for enhancing 1-4 cm renal masses into the existing diagnostic algorithm for incidental renal masses and demonstrate its use in our case of suspected renal oncocytoma.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Intractable & rare diseases research
Intractable & rare diseases research MEDICINE, GENERAL & INTERNAL-
CiteScore
2.10
自引率
0.00%
发文量
29
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信